Pelletier EM - Search Results

1

Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis.

Pelletier EM, Shim B, Goodman S, Amonkar MM. Pelletier EM, et al. Breast Cancer Res Treat. 2008 Mar;108(2):297-305. doi: 10.1007/s10549-007-9601-0. Epub 2007 Jun 19. Breast Cancer Res Treat. 2008. PMID: 17577662

2

Economic outcomes associated with microvascular complications of type 2 diabetes mellitus: results from a US claims data analysis.

Pelletier EM, Shim B, Ben-Joseph R, Caro JJ. Pelletier EM, et al. Pharmacoeconomics. 2009;27(6):479-90. doi: 10.2165/00019053-200927060-00004. Pharmacoeconomics. 2009. PMID: 19640011

3

Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: results from an analysis of data from a US claims database.

Pelletier EM, Ogale S, Yu E, Brunetta P, Garg J. Pelletier EM, et al. Clin Ther. 2009 Nov;31(11):2653-64. doi: 10.1016/j.clinthera.2009.11.032. Clin Ther. 2009. PMID: 20110008

4

Economic outcomes of exenatide vs liraglutide in type 2 diabetes patients in the United States: results from a retrospective claims database analysis.

Pelletier EM, Pawaskar M, Smith PJ, Best JH, Chapman RH. Pelletier EM, et al. J Med Econ. 2012;15(6):1039-50. doi: 10.3111/13696998.2012.688903. Epub 2012 May 24. J Med Econ. 2012. PMID: 22533526 Free article.

5

Direct medical costs for type 2 diabetes mellitus complications in the US commercial payer setting: a resource for economic research.

Pelletier EM, Smith PJ, Boye KS, Misurski DA, Tunis SL, Minshall ME. Pelletier EM, et al. Appl Health Econ Health Policy. 2008;6(2-3):103-12. doi: 10.1007/BF03256126. Appl Health Econ Health Policy. 2008. PMID: 19231904

6

Clinical and economic outcomes of percutaneous coronary interventions in the elderly: an analysis of medicare claims data.

Clark MA, Bakhai A, Lacey MJ, Pelletier EM, Cohen DJ. Clark MA, et al. Among authors: pelletier em. Circulation. 2004 Jul 20;110(3):259-64. doi: 10.1161/01.CIR.0000135589.85501.DB. Epub 2004 Jun 28. Circulation. 2004. PMID: 15226211

7

Patient out-of-pocket payments for oral oncolytics: results from a 2009 US claims data analysis.

Raborn ML, Pelletier EM, Smith DB, Reyes CM. Raborn ML, et al. Among authors: pelletier em. Am J Manag Care. 2012 May;18(5 Spec No. 2):SP57-64. Am J Manag Care. 2012. PMID: 22693982 Free article.

8

Patient Out-of-Pocket Payments for Oral Oncolytics: Results From a 2009 US Claims Data Analysis.

Raborn ML, Pelletier EM, Smith DB, Reyes CM. Raborn ML, et al. Among authors: pelletier em. J Oncol Pract. 2012 May;8(3 Suppl):9s-15s. doi: 10.1200/JOP.2011.000516. J Oncol Pract. 2012. PMID: 22942827 Free PMC article.

9

Pharmacotherapy adherence and costs versus nonpharmacologic management in overactive bladder.

Pelletier EM, Vats V, Clemens JQ. Pelletier EM, et al. Am J Manag Care. 2009 Mar;15(4 Suppl):S108-14. Am J Manag Care. 2009. PMID: 19355799 Free article.

10

Clinical and economic effects of coronary restenosis after percutaneous coronary intervention in a managed care population.

Clark MA, Bakhai A, Pelletier EM, Cohen DJ. Clark MA, et al. Among authors: pelletier em. Manag Care. 2005 Apr;14(4):42-4, 46-51. Manag Care. 2005. PMID: 15898211

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters